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Abstract
Background: General (GA)- and epidural-anesthesia may cause a drop in body-core-temperature (BCTdrop), and
hypothermia, which may alter tissue oxygenation (StO2) and microperfusion after cytoreductive surgery for ovarian
cancer. Cell metabolism of subcutaneous fat- or skeletal muscle cells, measured in microdialysis, may be affected.
We hypothesized that forced-air prewarming during epidural catheter placement and induction of GA maintains
normothermia and improves microperfusion.
Methods: After ethics approval 47 women scheduled for cytoreductive surgery were prospectively enrolled. Women in
the study group were treated with a prewarming of 43 °C during epidural catheter placement. BCT (Spot on®, 3 M) was
measured before (T1), after induction of GA (T2) at 15min (T3) after start of surgery, and until 2 h after ICU admission
(TICU2h). Primary endpoint was BCTdrop between T1 and T2. Microperfusion-, hemodynamic- and clinical outcomes were
defined as secondary outcomes. Statistical analysis used the Mann-Whitney-U- and non-parametric-longitudinal tests.
Results: BCTdrop was 0.35 °C with prewarming and 0.9 °C without prewarming (p < 0.005) and BCT remained higher over
the observation period (ΔT4 = 0.9 °C up to ΔT7 = 0.95 °C, p< 0.001). No significant differences in hemodynamic parameters,
transfusion, arterial lactate and dCO2 were measured. In microdialysis the ethanol ratio was temporarily, but not
significantly, reduced after prewarming. Lactate, glucose and glycerol after PW tended to be more constant over
the entire period. Postoperatively, six women without prewarming, but none after prewarming were mechanical
ventilated (p < 0.001).
Conclusion: Prewarming at 43 °C reduces the BCTdrop and maintains normothermia without impeding the perioperative
routine patient flow. Microdialysis indicate better preserved parameters of microperfusion.
Trial registration: ClinicalTrials.gov; ID: NCT02364219; Date of registration: 18-febr-2015.
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Background
The incidence of inadvertent perioperative hypothermia
in surgery, defined as a body core temperature (BCT)
below 36 °C, is still high [1, 2]. A shift of thresholds for
vasoconstriction and shivering as well as sympathicolysis-
related vasodilatation caused by epidural anesthesia (EDA)
result in a redistribution of warm blood from the body core
to the periphery [3]. Furthermore, the induction of general
anesthesia (GA) aggravates redistribution hypothermia up
to 1.5 °C [4]. Cytoreductive surgery for ovarian cancer is
characterized by maximum extent of tumour debulking
including deperitonea-lisation and massive volume shifts
and losses [5]. Stabilisation of the BCT, therefore, requires
forced air warming and administration of warmed infusions
and transfusions. However, maintainance of normothermia
is jeopardized by an anesthesia-reduced base metabolic
rate and heat production [5]. Perioperative hypothermia
may affect coagulation by altered platelet function [6, 7]
and increase intraoperative blood loss [8]. Furthermore,
hypothermia-related vasoconstriction may impair micro-
perfusion and reduce the oxygen partial pressure and
oxygen saturation (StO2) in peripheral tissues [9]. As a
result of impaired microperfusion cell metabolism of sub-
cutaneous fat- or skeletal muscle cells, measured in micro-
dialysis (MD), may be affected [10].
Preoperative forced-air warming (prewarming) of 10 to
60min at 43 °C [11–15] before induction of GA has
been shown to reduce the temperature gradient between
body core and periphery [16] in order to alleviate redis-
tribution hypothermia [3, 16] and to maintain intraoper-
ative normothermia [17] in minor surgery (without
EDA) [11] or major abdominal surgery with EDA [12].
However, these studies required holding areas to realize
prewarming and a timely patient flow. From a surgical
point of view, in major cytoreductive surgery with a dur-
ation of more than 180 min it still remains unclear
whether a brief prewarming during insertion of EDA is
effective to maintain intra- and postoperative normo-
thermia and to improve intraoperative hemodynamics
and microperfusion as well as to reduce postoperative
shivering and ventilation [18].
We hypothesized that a forced-air prewarming interval
of 30 min at 43 °C during epidural catheter placement
and induction of GA without any changes of the peri-
operative patient flow (e.g. no treatment in a preoperative
holding area) is effective to maintain perioperative normo-
thermia and improve microperfusion during cytoreductive
surgery for ovarian cancer.
Methods
This single-center prospective randomized clinical trial
was conducted at the Departments of Anesthesiology and
Intensive Care Medicine and Gynecology of the Charité-
Universitätsmedizin Berlin, Germany. Ethics approval was
obtained from the institutional ethics committee (EA1/
348/14, ClinicalTrials.govID: NCT02364219). Women
were enrolled if they were of age (> 18 years), mentally
healthy, American Society of Anesthesiologists physical
status Class I–III and scheduled to undergo elective
major cytoreductive surgery in primary or secondary
ovarian cancer under combined epidural and general
anesthesia. Exclusion criteria were: heart failure (left
ventricular ejection fraction (LV-EF) < 30%), chronic ob-
structive pulmonary disease (GINA-Classification > 3),
renal failure (glomerular filtration rate (GFR) < 50ml/min)
or dialysis, participation in another clinical trial and contra-
indication of EDA including non-eligibility due to refusal of
neuraxial anesthesia.
After written informed consent and before surgery,
women were prospectively randomized into prewarm-
ing (prewarm) and standard group (standard) using a
computer-generated block randomization (Excel, Microsoft
Corporation, Redmont, WA, USA). Additionally, a sub-
group of the standard- and the prewarm group were ran-
domly assigned for microdialysis (MD) measurements. The
randomization was concealed. Randomization was blinded,
the anesthesist during surgery was not randomized and the
data evaluation took place independently from the surgery
anesthesist.
According to randomization, women in the prewarming
group received forced-air warming at 43 °C, during the
establishment of epidural anesthesia. Prewarming was
applied using a forced air warming gown (Bair Paws™ Flex
Warming Gown, 3M™, St. Paul, MN, USA) connected to
a forced air warmer (Bair Hugger™, Model 750, 3M™, St.
Paul, MN, USA), which warms the front of the body in-
cluding upper arms (Fig. 1a). In the standard treatment
group, patients were covered by a cotton blanket for pas-
sive insulation without active warming during the inser-
tion of the epidural catheter.
The perioperative anesthetic setting in both groups
was based on the clinical practice and standard operating
procedures of the Department. Upon arrival in the operat-
ing room (OR), a peripheral vein cannula was inserted and
an infusion of balanced crystalloid solution was started
under standard monitoring. Body core temperature was
taken by using the SpotOn™ temperature system (3M™; St.
Paul, MN, USA) in both groups and throughout the obser-
vation period [19]. Perioperative body core temperatures
were manually recorded in the case reporting form (CRF)
at admission to the OR (T1), insertion of epidural catheter
and induction of GA (T2) as well as after 15 min (T3),
60 min (T4), 120 min (T5), 180 min (T6), at the end of
operation (T7), on admission to the ICU (TICU) and 2 h
postoperatively (T ICU2h). In both groups, a thoracic
epidural catheter was inserted in the sitting position
(Fig. 1a). After induction of GA, EDA was established
by a bolus followed by a continuous rate of ropivacaine/
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sufentanil (CADD™ Solis pump, Smiths Medical, St.
Paul, MN, USA). GA was induced using propofol,
fentanyl and rocuronium for endotracheal intubation
and maintained with sevoflurane with a minimum in-
spired oxygen concentration of 40% and an end-tidal
CO2 concentration of 35 to 40 mmHg. Anaesthesia and
muscle relaxation was maintained with repetitive bolusses
of fentanyl and rocuronium. A central venous line (Arrow
Medical Limited, Kington, UK) was placed into the in-
ternal jugular vein and blood pressure was measured by
an arterial line (Vygon, Ecouen, France). During surgery,
all intravenous (i.v.) fluids were infused using an active
warming device (Level 1, Hot Line™, Smiths Medicals, St.
Paul, MN, USA). Women were warmed by forced air
warming of the upper part of the body (Standard-group:
3M™ Bair Hugger™ Intraoperative Blanket; PW-group:
3M™Bair Paws™ Flex Warming Gown) at 43 °C until end
of anesthesia. Forced air warming was shortly paused in
both groups during disinfection of the belly before sur-
gery. Postoperatively, women were transferred to the post-
anesthesia care unit (PACU). If patients showed clinical
signs of hypovolemia (such as heart rate (HR) > 100 bpm,
mean arterial pressure (MAP) < 60mmHg, increased pulse
pressure variation (PPV)) as well as hypovolemic changes
in the hemodynamic monitoring (stroke volume variation
(SVV), stroke volume (SV) and CO; Flo-Trac™, Edwards
Lifesciencess, Irvine, CA, USA) and in case of intraopera-
tive volume- and blood loss, crystalloid infusion, gelatine
infusion (500–1000ml Gelafundin™ 4% BBraun, Melsun-
gen, Germany) and, if needed, fresh frozen plasma (FFP)
and red blood cell concentrates (RBC) were given accord-
ing to the transfusion- and hemodynamic algorithm of the
standard operating procedures (SOP) of the Department
of Anesthesiology and Intensive Care Medicine [20].
During surgery, StO2 was measured by near-infrared spec-
troscopy (InSpectra Spot Check, M300™, Hutchinson,
MN, USA) on the thenar of the right hand. Central venous
and arterial blood gas analysis to determine dCO2, lactate
and hemoglobin (Hb) were performed every 30 min.
Patients were extubated when spontaneous breathing
was sufficient, body core temperature > 35.5 C and no
clinical symptoms of hypovolemia or hemodynamic
instability. Postoperative pain relief was achieved using
a patient-controlled epidural analgesia (PCEA) and
women were transferred to PACU for at least 24 h after
operation [20].
For MD, a 60mm (inlet tubing diameter 1mm) flexible
catheter (63 MD catheter, molecular weight cut-off of
2kD, M Dialysis AB, Stockholm, Sweden) was placed into
the subcutaneous fat tissue below the right deltoid muscle
after local anesthesia (Fig. 1b). After perfusion with iso-
tonic sterile fluid (perfusion fluid T1, M Dialysis AB) at a
rate of 1 μl/min (MD Pump 106, M Dialysis AB) a dialys-
ate was collected every 30min (first sample at T3) in a
200 μl microvial (M Dialysis AB) and stored at − 20 °C
until analysis. At the end of surgery, the catheter was
removed while the patient was still unconscious. All MD
analysis were performed by the Experimental & Clinical
Research Center (ECRC) of the Franz-Volhard-Centrum,
Charité-Universitätsmedizin Berlin, Campus Berlin-Buch.
The primary endpoint was defined as body core
temperature drop (BCTdrop) from before epidural catheter
placement (T1) and after induction of GA (T2) in the pre-
warming or standard group. Intra- and postoperative
change of BCT up to 2 h after ICU admission, StO2 and
hemodynamic parameters (PPV, SVV, SV), MAP, HR,
norepinephrine usage, intraoperative transfusion rates
(FFP, RBC), arterial lactate as well as the ethanol ratio, the
glucose-, lactate- and glycerol concentration via MD were
defined as secondary endpoints. In addition, the central
venous-arterial dCO2, which depends on the CO2 produc-
tion of the tissues and CO, were measured as a marker for
Fig. 1 a) Forced air prewarming during insertion of the epidural catheter; b) subcutaneous microdialyses in the upper arm
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microperfusion [21]. Postoperatively, shivering and post-
operative ventilation were obtained.
Sample size calculation was based on the assumption of
a minimal difference of 0.5 °C in body core temperature
after prewarming compared to no prewarming (standard)
[11]. A sample size of totally 48 patients, divided into two
groups, was calculated to provide 80% power for detecting
statistically significant difference at a two-tailed signifi-
cance level of 0.05 (nQuery Advisor™, Release 7.0, Stat. So-
lutions Ltd. & South Bank, Crosse’s Green, Cork, Ireland).
A dropout rate of 10% of patients not eligible for data
sampling was included.
Data are reported as arithmetic mean [standard devi-
ation (SD)] or median [25, 75% percentile] (after rejec-
tion of normal distribution) or frequencies (%). In order
to assess differences in body core temperature as the pri-
mary outcome at timepoints T1-T7 the nonparametric
(exact) Mann-Whitney-U test was used. Differences
between the groups in terms of patient characteristics as
well as secondary outcomes were compared with paired
or unpaired t-test and chi-squared test. Frequencies were
tested by the exact Mantel-Haenszel test (for ordered
categories) or the exact Chi-square test (for unordered
categories). A two-tailed p-value of < 0.05 was consid-
ered statistically significant.
For MD subgroup analysis a sample size of 7 patients
for each group was defined according to the study of
Rosdahl et al. [10].
All calculations were performed with R software (ver-
sion 3.3; R Foundation for Statistical Computing, Vienna,
Austria).
The reporting of this RCT follows the updated guidelines
for reporting parallel group randomized trials (CONSORT
2010 statement).
Results
During January 2015 and December 2017 133 women
were screened for eligibility. 85 patients did not meet
the inclusion criteria (Fig. 2) and were excluded before
randomization, leaving 48 women for randomization
(Fig. 2). Data of 47 women were analyzed, as one woman
had to be excluded due to termination of the procedure
out of surgical reasons (Fig. 2).
133 women
screened for eligibility
85 women meeting
exclusion criteria
48 women enrolled
0 womens excluded
after enrollment
48 women
randomised
prewarm – group
24 women
standard - group
24 women
(23 analysed)
7 women
prewarm
with MD
16 women
prewarm
without MD
7 women
standard
with MD
16 women
standard
without MD
Fig. 2 CONSORT flow diagram
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Besides a slight difference in height (p = 0.047), patient
baseline characteristics, comorbidities and the duration
of surgery did not differ significantly between the groups
(Table 1). In multivariable linear regressions with group
and BMI, group and age or group, BMI, and age as inde-
pendent variables only group showed a significant rela-
tionship (p < 0.05) with body core temperature change.
Regarding the primary endpoint, the body core
temperature change from T1 (before) to T2 amounted
to 0.35 °C in the prewarm group and 0.9 °C in the
standard group (Fig. 3) with a significant difference
(ΔT) at T2 = 0.55 °C (p < 0.005) between both groups
(Fig. 3). No significant difference in baseline body core
temperature (T1) was measured (Fig. 4). After a fur-
ther decrease of the BCT between T2 and T3 with a
significant ΔT3 of 0.85 °C (p < 0,001) (Fig. 4) the BCT
increased in both groups during the operation (Fig. 4).
The core temperature remained higher in the prewarm
Table 1 Patient baseline characteristics, comorbidities and duration of surgery
prewarm n=24 standard n= 23
Age (Years, mean±SD) 54,4 (±11,7) 61,3 (12,1)
Weight (kg, mean±SD) 73,6 (17,6) 67,8 (10,3)
Height (cm, mean±SD) 167 (4,9) 164,0 (6,1)*
BMI (mean±SD) 26,3 (5,8) 25,4 (4,1)
FIGO stage (n, %)
I 1 (4) 0 (0)
II 0 (0) 0 (0)
III 17 (68) 14 (64)
IV 5 (20) 4 (18)
Residual tumor after surgery (n, %):
0 cm 18 (72) 17 (77)
0-1 cm 5 (20) 4 (18)
1-2 cm 1 (4) 1 (5)
>2 cm 2 (8) 0 (0)
Preoperative fasting (Liquids in hrs, mean±SD) 11,3 (4,2) 11,6 (3,8)
Preoperative fasting (Solid in hrs, mean±SD) 16,7 (4,7) 16,2 (4,8)
Coronary artery disease (n,%) 0 (0) 1 (4,4)
Heart failure (n,%) 0 (0) 0 (0)
Diabetes mellitus (n,%) 1 (4,2) 1 (4,4)
Hypothyroidism (n,%) 1 (4,2) 4 (17.4)
Renal failure (n,%) 0 (0) 1 (4,4)
Arterial hypertension (n,%) 5 (20,8) 7 (30,4)
Peripheral arterial vascular disease (n,%) 1 (4,2) 1 (4,4)
COPD (n,%) 1 (4,2) 1 (4,4)
Asthma (n,%) 3 (12,5) 2 (8,7)
Thrombosis (n,%) 3 (12,5) 1 (4,4)
Hyperthyroidism (n,%) 1 (4,2) 1 (4,4)
Nicotine abuse (n,%) 0 (0) 1 (4,4)
Hyperlipoproteinemia (n,%) 0 (0) 3 (13)
ASA Classification (n,%):
1 4 (16,7) 3 (13)
2 12 (50) 14 (60,9)
3 8 (33,3) 6 (26,1)
Duration of surgery§ (min, mean ± SD) 334 ±114 364 ±134
*p < 0.05; § incision to suture; SD Standard deviation, BMI body mass index, FIGO International Federation of Gynecology and Obstetrics, COPD chronic obstructive
pulmonary disease, ASA American Society of Anesthesiologists
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group over the entire observation period with a signifi-
cant ΔT at all time points from (ΔT4 = 0.9 °C up to
ΔT7 = 0.95 °C, p < 0,001, Fig. 4). At TICU and at TICU2h
the body core temperatures in the PREWARM group
were also higher than in the standard group (Fig. 5).
One woman in the prewarm group suffered from
hypothermia (< 36 °C) temporarily while 17 women in
the standard group were hypothermic at one time
point and/or over the entire intraoperative observation
period (p < 0,001). At TICU six women in the standard
group, but none in the prewarm group were subject to
postoperative ventilation (p < 0.001) due to hypothermia
at a median core temperature of 34.9 °C (34.8; 35.0). Three
women in the standard group at TICU only, but none in
the PREWARM group experienced postoperative shiver-
ing (p > 0.05).
StO2 increased from 86% (T3) to 88% (T7) in the pre-
warm group and was slightly, but not significantly, higher
compared to 82% (T3) and 85% (T7) in the standard group.
In both groups, the dCO2 did not change intraoperatively
(median: prewarm 6.25mmHg; standard 6.15mmHg).
Hemodynamic parameters such as SVV, SV and PPV as
well as MAP, HR and norepinephrine concentration varied
temporarily, depending on the volume changes in both
groups, but without any significant differences between
both groups at T3, T4 and T5 (Table 2). FFP- and RBC
transfusion were used in both groups with a non-significant
difference between the groups (Table 2). The intraoperative
arterial lactate concentration varied within the scope
of 6 mg/dl (T3) to 7.5 mg/dl (T7) without significant
differences between both groups.
For the ethanol ratio, the glucose-, lactate- and glycerol
concentration [median (25. quartile/75. quartile)] measured
by MD from T3 to T7, no significant differences were de-
tectable between the groups. On closer view, the ethanol ra-
tio (Fig. 6) was temporarily reduced in the prewarm
compared to the standard group, with comparable results
at the end of surgery (T6). The glucose concentration de-
ferred from 2.05 (0.36/0.36) mmol/l in the prewarm group
versus 1.02 (0.42/0.59) mmol/l in the standard group at T3
and proceeded almost similar in both groups between 1.51
(0.44/0.87) and 2.1 (1.35/0.35) mmol/l from T4 to T7. The
glycerol concentration decreased continuously from 315
(163/278) μmol/l at T3 to 191 (21/185) μmol/l at T7 in the
prewarm group and from 245 (106/187) μmol/l at T3 to
119 (52/131) μmol/l at T7 in the standard group. The lac-
tate concentration of 0.66 (0.17/0.07) mmol/l at T3 in the
prewarm group was higher compared to 0.48 (0.25/0.18)
mmol/l in the standard group and both concentrations
aligned at 0.6 (0.17/0.02) mmol/l at T6.
Fig. 4 Secondary endpoints: Body core temperature before prewarming (T1) and during operation (T3 to T6) and at the end of surgery (T7)
[median and quartile (25%; 75%); * p < 0,001]
Fig. 3 Primary endpoint: Body core temperature drop between T1
and after induction of general anesthesia T2 with (prewarm) or
without (standard) prewarming [median and quartile (25%; 75%)]
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Discussion
In this study a forced-air prewarming interval at 43 °C
during epidural catheter placement and induction of GA
showed efficacy to reduce core temperature drop and to
maintain intraoperative normothermia during cytore-
ductive surgery not only throughout extended surgery
but also at ICU admission and two hours thereafter. Fur-
thermore, prewarming reduced the risk of postoperative
ventilation due to hypothermia at the end of surgery.
Microdialysis and StO2 showed better results for the
prewarming group, however, this did not reach statistical
significance. A reason for this may have been, that all
hemodynamic parameters, transfusion rates, and dCO2
were not different in either study group. Nevertheless,
small sample size for secondary outcomes should be
taken into account for further discussions.
In a prospective randomized trial in 99 patients under-
going major abdominal surgery, Horn et al. [12] analyzed
the effects of prewarming over 15 min before and after
EDA versus 15 min after EDA or no prewarming. In
contrast to our study, forced-air prewarming was per-
formed at 44 °C in a preoperative care unit before and
after EDA, which requires higher logistical and staff de-
mands than our approach [12]. Nevertheless, despite
pre- and intraoperative forced-air warming the drop in
body core temperature with induction of GA still occurs,
which can be significantly alleviated by prewarming,
which is in line with earlier results [12, 22].
At ICU admission only six women of the standard
group but none in the prewarming group were mechan-
ically ventilated on ICU because of hypothermia. These
findings are in line with the findings of Horn et al. who
measured a 34% postoperative ventilation rate in non-
prewarmed patients, which indicates the importance of
temperature management for ventilation times after sur-
gery. Even 2 h after ICU admission prewarmed women
of our study had a higher body core temperature without
any shivering. Our data suggest, that the greater body
core temperature drop after induction of GA in the
standard seems to be irreversible in spite of all intraop-
erative approaches, such as intraoperative forced air
warming, warm fluids etc., to warm up the patients dur-
ing surgery effectively.
We hypothesized that StO2, dCO2, arterial lactate and
parameters of MD may be useful as surrogate parame-
ters to measure an improved microperfusion in pre-
warmed and normothermic patients. These markers did
not differ significantly, but showed a trend in favor of
the prewarm group, which may indicate the need for
further studies powered to detect a difference in micro-
circulation parameters.
We measured a non-significant difference in StO2 in
favor of the prewarmed patient group. It still remains
unclear if this effect is caused by mild hypothermia-in-
duced vasoconstriction and consecutive hypoperfusion
and could be prevented by measures to maintain normo-
thermia [23].
Our MD data could suggest that the tendency of a tem-
porarily reduced ethanol ratio in prewarmed women after
induction of GA and during the first hours of operations
may represent an improved tissue perfusion [10]. After
normothermia is reestablished due to intraoperative
forced-air- warming and warmed transfusion/iv-fluids, the
ethanol ratios showed similar values. This is consistent
with the other microdialysis parameters. In 13 healthy vol-
unteers, Rosdahl et al. demonstrated that the availability
of glucose as a substrate for cell metabolism in subcutane-
ous fat tissue is dependent on tissue perfusion [10].
Fig. 5 Secondary endpoints: Body core temperature at TICU and TICU2h
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Therefore, the glucose recovery rate in MD acts ap-
proximately inverse to the ethanol ratio [10]. This might
explain the increased glucose concentration in the pre-
warmed group at the beginning of surgery when perfusion
may be improved due to the higher body core temperature
compared to the standard group. Moreover, an increase of
the lactate concentration in MD represents hypoperfusion
and oxygen deficit in the subcutaneous tissue, as Bahlmann
et al. demonstrated after 15–60min of aortic clamping [24].
Potential hypoperfusion of the subcutaneous tissue due to
reduced body core temperature did not result in an in-
crease of the lactate concentration in the standard group
with MD. On the other hand, the glycerol concentration in
MD represents increased metabolic stress and lipolytic ac-
tivity in the standard group [24]. Unfortunately and similar
to lactate, the concentration remained without significant
changes and differences between the groups. It may be
hypothesized that mild hypothermia or reduced body core
temperature are not very likely to result in a detectable
increase of lactate and glycerol in MD. Nevertheless, the
MD parameters give a first impression of temperature-re-
lated effects on microperfusion and that MD may be a
promising technique to identify surrogate parameters for
the impact of hypothermia. So far, no comparable data of
MD in dependence of changes in body core temperature
are published.
Limitations
Our study has a few limitations: Firstly, the study was
powered in regards to primary outcome. In terms of sec-
ondary outcome, the study was not powered to detect sig-
nificant changes, but may allow for an estimation of the
number of patients needed for upcoming investigations
on microperfusion and MD. Secondly, StO2 was evaluated
without reference values of an accompanied vascular oc-
clusion test on the upper arm due to potential disruption
Fig. 6 Secondary endpoints: Ethanol ratio in MD before prewarming (T1) and during operation (T4to T6) and at the end of surgery (T7) [median
and quartile (25%; 75%)]
Table 2 Secondary endpoints: Intraoperative hemodynamic
parameters at T3–5 and total amount of transfusion at the end
of surgery
prewarm [mean; (SD)] standard [mean; (SD)]
MAP (mmHg)
T3 80 (±12) 77 (±18)
T4 77 (±10) 74 (±17)
T5 78 (±9) 75 (±17)
HR (bpm)
T3 62 (±13) 60 (±15)
T4 68 (±12) 65 (±15)
T5 72 (±16) 71 (±19)
SVV (%)
T3 9 (±3) 8 (±3)
T4 9 (±3) 9 (±3)
T5 9 (±3) 9 (±3)
SV (ml)
T3 69 (±12) 67 (±16)
T4 74 (±18) 73 (±21)
T5 81 (±21) 77 (±24)
PPV (%)
T3 7 (±3) 7 (±3)
T4 9 (±3) 8 (±3)
T5 9 (±5) 9 (±5)
Norepinephrine (μg/kg/min)
T3 0.03 (± 0.02) 0.03 (±0.02)
T4 0.06 (±0.04) 0.06 (±0.04)
T5 0.07 (±0.05) 0.07 (±0.04)
Transfusion (ml)
FFP at T7 3500 (±2300) 3700 (±2200)
RBC at T7 1000 (±600) 1000 (±900)
*p < 0.05; MAP mean arterial pressure, HR heart rate, SVV Stroke volume
variation, SV Stroke volume, PPV pulse pressure variation, FFP fresh frozen
plasma, RBC red blood cells concentrates
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and damage to the microdialysis catheter, which was
inserted on the same side. Lastly, prewarming did not
allow a blinding at all times. A concealed randomization
was performed. Furthermore the anesthesiologist in
charge of the patient was not involved in the collec-
tion of study related data. So the likelihood of bias
was reduced.
Conclusion
In conclusion, forced-air prewarming at 43 °C during
epidural catheter placement and induction of GA with-
out interfering with the perioperative routine setting is
effective to reduce the core temperature drop. Further-
more, prewarming maintains intraoperative normother-
mia until the end of surgery and up to two hours after
ICU admission without any shivering or mechanically
ventilation due to hypothermia postoperatively. A statisti-
cally significant impact of prewarming on microperfusion
as measured by MD could not be detected by this study.
However, reduced ethanol ratio and increased glucose con-
centration in the microdialysis as well as an increased tissue
oxygenation may point to a better maintained microperfu-
sion in prewarmed patients compared to those receiving
standard treatment. The use of hemodynamic parameters,
transfusion rates, StO2, dCO2 and MD parameters as
surrogate parameters influencing microperfusion should
be controlled in further randomized, controlled studies
investigating the impact of temperature management in
surgical patients.
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